Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1

Endocrine Reviews

Volumn 21, Issue 4, 2000, Pages 393-411

  Yamaguchi, Akira ^a   Komori, Toshihisa ^b,c   Suda, Tatsuo ^d  

^a NAGASAKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CORE BINDING FACTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; GENE LOCUS; HETEROZYGOSITY; MULTIGENE FAMILY; MUSCLE CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STEM CELL;

EID: 0034455051     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.21.4.0403     Document Type: Review

References (223)

1. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine
2. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone
3. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential
4. The osteoblast lineage
5. Marrow stromal stem cells
6. Mesenchymal stem cells
7. Multilineage potential of adult human mesenchymal stem cells
8. Anabolic actions of parathyroid hormone on bone
9. Anabolic actions of parathyroid hormone on bone: Update 1995
10. Regulated expression of the bone specific osteocalcin gene by vitamins and hormones
11. Skeletal effects of estrogen
12. Recent advances in bone biology provide insight into the pathogenesis of bone diseases
13. Mechanisms of glucocorticoid action in bone cells
14. Glucocorticoid-induced osteoporosis: Both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation
15. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines
16. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin
17. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria
18. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
19. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
20. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formarion in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro
21. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
22. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells
23. The world according to hedgehog
24. Patterning of mammalian somites by surface ectoderm and notochord: Evidence for sclerotome induction by a hedgehog homolog
25. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function
26. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein
27. Recapitulation of signals regulating embryonic bone formarion during postnatal growth and in fracture repair
28. Does adult fracture repair recapitulate embryonic skeletal formation?
29. Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair
30. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo
31. The MyoD family and myogenesis: Redundancy, networks, and thresholds
32. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
33. Cbfa1/Osf2: A transcriptional activator of osteoblast differentiation
34. Target disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
35. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
36. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex
37. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
38. Toward a molecular understanding of skeletal development
39. The development of fibroblast colonies in monolayer cultures of guinea pig bone marrow and spleen cells
40. Precursor cells of mechanocytes
41. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method
42. Osteogenic stem cells in the bone marrow
43. Osteogenic stem cells and the stromal system of bone and marrow
44. An autoradiographic study of periosteal cell proliferation with tritiated thymidine
45. Dexamethasone stimulates osteogenesis in chick periosteum in vitro
46. Bone: Formation by autoinduction
47. Novel regulators of bone formation: Molecular clones and activities
48. Future potentials for using osteogenic stem cells and biomaterials in orthopedics
49. Bone morphogenetic protein
50. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography
51. Purification and characterization of other distinct bone-inducing factors
52. Purification and partial amino acid sequence of osteogenic, a protein initiating bone differentiation
53. Bone morphogenetic protein
54. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system
55. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5
56. Drosophila transforming growth factor β superfamily proteins induce endochondral bone formation in mammals
57. BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice
58. Colocalization of BMP 7 and BMP-2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development
59. GDF5 coordinates bone and joint formation during digit development
60. Limb alterations in brachypodism mice due to mutations in a new member of the TGF β-superfamily
61. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse
62. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis
63. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development
64. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye
65. Bmp-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
66. What do BMPs do in mammals?
67. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development
68. Bmp4 is required for the generation of primordial germ cells in the mouse embryo
69. TGF-β signaling from cell membrane to nucleus through SMAD proteins
70. Signal transduction by bone morphogenetic proteins
71. Cloning and characterization of a human type II receptor for bone morphogenetic proteins
72. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors
73. Human type II receptor for bone morphogenetic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
74. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4
75. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH3T3 cells
76. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo
77. Distinct spatial and temporal expression pattern of two type I receptors for bone morphogenetic proteins during mouse embryogenesis
78. Cloning of rat type I receptor cDNA for bone morphogenetic proteins and bone morphogenetic-4, and the localization compared with that of the ligands
79. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts
80. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development
81. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: High affinity binding to basement membranes
82. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development
83. Cartilage derived morphogenetic proteins: New members of the transforming growth factor-β superfamily predominantly expressed in long bones during human embryonic development
84. Bone morphogenetic proteins: From basic studies to clinical approaches
85. Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4
86. Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo
87. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts
88. TGF-β signaling through the Smad pathway
89. Smad8 mediates the signaling of the ALK-2 receptor serine kinase
90. MADR1, a MAD-related protein that functions in BMP2 signaling pathway
91. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily
92. A human Mad protein acting as a BMP-regulated transcriptional activator
93. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
94. Smad1 and Smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts
95. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12
96. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
97. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4
98. Receptor-associated Mad homologues synergize as effectors of TGF-β response
99. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways
100. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
101. Smad6 inhibits signaling by the TGF-β superfamily
102. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling
103. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
104. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells
105. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells
106. Induction of osteogenic differentiation by hedgehog proteins
107. Expression of human bone morphogenetic protein-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells mesenchymal cell lineages
108. Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production
109. An immortalized osteogenic cell line derived from mouse teratocarcinoma is able to mineralize in vivo and in vitro
110. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways
111. Intracellular signaling of osteogenic protein-1 through Smad5 activation
112. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells MC3T3-E1
113. Interleukin-1β enhances and tumor necrosis factor-α inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells
114. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells
115. Effects of GDF7/BMP12 on proliferation and alkaline phosphatase expression in rat osteoblastic osteosarcoma ROS 17/2.8 cells
116. Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts
117. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations
118. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats
119. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvarial cells
120. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells
121. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblastic cells in vitro
122. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6
123. Effects of osteogenic protein-1 (OP-1 BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific
124. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation
125. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2
126. Effects of recombinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin
127. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2
128. Stimulation of bone formation in vitro and in rodents by statins
129. The bone marrow-derived stromal cell lines MC3T3-G3/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
130. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells
131. Effects of BMP-2, BMP-4 and BMP-6 on osteoblast differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6
132. B cell ontogeny in murine embryonic studies by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac
133. A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hematopoietic stem cells in vitro
134. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid
135. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages
136. Morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells
137. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases CBFA1/OSF2, enhances osteoblast commitment, and inhibits late adipocyte maturation
138. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2
139. Substrata prepared from bone matrix for chondrogenesis in tissue culture
140. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin
141. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2
142. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation
143. Induction of Smad6 mRNA by bone morphogenetic proteins
144. The Spemann organizer signal noggin bonds and inactivates bone morphogenetic protein 4
145. Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4
146. The Xenopus dorsaling factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities
147. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo
148. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite
149. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
150. Cleavage of chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity
151. Production of DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and TLD proteins
152. Bone morphogenetic protein-3/osteogenin antagonizes BMP2-induced osteogenic differentiation and is a negative regulator of bone formation
153. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly
154. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly
155. Exclusion of the sonic hedgehog gene as responsible for Currarino syndrome and anorectal malformations with sacral hypodevelopment
156. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
157. Human developmental disorders and the sonic hedgehog pathway
158. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth
159. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation
160. Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud
161. Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation
162. Cooperation of BMP7 and SHH in the induction of forebrain ventral midline cells by prechordal mesoderm
163. Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling
164. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation
165. Developmental patterning in chondrocytic cultures by morphogenic gradients: BMP induces expression of Indian hedgehog and noggin
166. Hedgehog proteins induce chondrogenic cell differentiation and cartilage formation
167. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets
168. Multiple copies of the bone-specific osteocalcin gene in mouse and rat
169. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression
170. Msx-2/Hox 8.1: A transcriptional regulator of the rat osteocalcin promoter
171. Transcriptional control of the tissue specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins
172. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors
173. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: Minimal role of the proximal E-box cis-acting promoter elements
174. Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components
175. The tissue-specific nuclear matrix protein NMP-2, is a member of the AML/CBF/PEBP2/Runt domain transcriptional factor family: Interaction with the osteocalcin gene promoter
176. A PEBP2α/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element
177. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene
178. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene
179. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoters
180. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells
181. CBFa (AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation
182. Cbfa1 isoforms exert functional differences in osteoblast differentiation
183. Expression of transcription factor Cbfa1 is enhanced by the BMP-2/SMAD signal transduction cascade in pluripotent mesenchymal cells
184. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline C α promoter
185. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential
186. Morphological characterization of skeletal cells in Cbfa1-deficient mice
187. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
188. PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene
189. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α
190. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating oncogene
191. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells
192. Two domains unique to osteoblast-specific transcription factor Cbfa1/Osf2 contribute to its transactivation function and its inability to heterodimerize with Cbfβ
193. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
194. Transcriptional regulation of osteopontin gene in vivo by PEBP2αA/CBFA1 and ETS1 in the skeletal tissues
195. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains
196. Auto-inhibition and partner proteins core-binding factorβ (CBFβ) and Ets-1, modulate DNA binding by CBFα2 (AML1)
197. Maturational disturbance of chondrocytes in Cbfa1-deficient mice
198. Regulation of chondrocyte differentiation by Cbfa1
199. Role of osteoblasts in hormonal control of bone resorption - A hypothesis
200. Modulation of osteoclast differentiation
201. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse
202. Cellular biology of bone-resorbing cells
203. Osteoprotegerin: A novel secreted protein involved In the regulation of bone density
204. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
205. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
206. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
207. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
208. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
209. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
210. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
211. Osteoclast differentiation factor is a ligand osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
212. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
213. Potential role of Cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of Osteoclast Differentiation Factor (ODF)
214. Identification of a binding site in the murine RANKL/OPGL gene promoter: A potential link between osteoblastogenesis and osteoclastogenesis
215. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene
216. Cleidocranial dysostosis, a review of 40 new cases
217. Cleidocranial dysplasia: Clinical and molecular genetics
218. Mutations involving the transcriptional factor CBFA1 cause cleidocranial dysplasia
219. Genetic mapping of cleidcranial dysplasia and evidence of microdeletion in one family
220. Cbfa1 is required for epithelialmesenchymal interactions regulating tooth development in mice
221. AML1, AML2 and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization
222. The cDNA cloning of the transcripts of human PEBP2αA/CBFA1 mapped to 6p12.3-p21.1 the locus for cleidocranial dysplasia
223. Missense mutations abolishing DNA binding of he osteoblast-specific transcriptional factor CBFA1/OSF2 in cleidocranial dysplasia